Tower Research Capital LLC (Trc) Novo Nordisk A S Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Novo Nordisk A S stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 17,022 shares of NVO stock, worth $2.06 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

17,022

Previous 8,962 89.94%

Holding current value

$2.06 Million

Previous $1.15 Million 111.22%

% of portfolio

0.04%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $989,042 - $1.18 Million	8,060 Added 89.94%	17,022 $2.43 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $511,060 - $680,279	5,005 Added 126.48%	8,962 $1.15 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $166,782 - $200,355	1,900 Added 92.37%	3,957 $409,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $22,007 - $48,288	242 Added 13.33%	2,057 $187,000
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $252,063 - $279,002	1,616 Added 812.06%	1,815 $293,000
Q1 2023 May 09, 2023	BUY	$132.34 - $159.14 $16,410 - $19,733	124 Added 165.33%	199 $32,000
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $803,069 - $1.06 Million	-7,831 Reduced 99.05%	75 $10,000
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $365,684 - $448,777	3,838 Added 94.35%	7,906 $788,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $49,348 - $58,225	478 Added 13.31%	4,068 $453,000
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $534,207 - $645,754	-5,738 Reduced 61.51%	3,590 $398,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $891,204 - $1.09 Million	9,295 Added 28166.67%	9,328 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $2,785 - $3,518	33 New	33 $3,000
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $380,925 - $477,198	-5,630 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $120,775 - $136,551	1,801 Added 47.04%	5,630 $380,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $22,808 - $26,346	-357 Reduced 8.53%	3,829 $267,000
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $253,231 - $279,194	3,976 Added 1893.33%	4,186 $291,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $1,170 - $1,358	-20 Reduced 8.7%	210 $14,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $11,375 - $14,899	230 New	230 $14,000
Q4 2019 Feb 07, 2020	SELL	$49.86 - $58.26 $17,600 - $20,565	-353 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$47.54 - $53.43 $16,781 - $18,860	353 New	353 $18,000
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $120,811 - $135,477	-2,582 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $118,867 - $134,943	2,564 Added 14244.44%	2,582 $135,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $747 - $850	18 New	18 $1,000
Q2 2018 Aug 15, 2018	SELL	$44.29 - $50.42 $15,678 - $17,848	-354 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $17,165 - $20,581	354 New	354 $17,000
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $68,158 - $77,048	-1,434 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $59,009 - $70,581	1,434	1,434 $69,000

Others Institutions Holding NVO

# of Institutions

1,991

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Novo Nordisk A S Transaction History